PFSA Company Profile and Key Details

PFSA has shown mixed momentum, gaining 7.46% over the past week and -68.01% over the past quarter, though year-to-date performance is down -9.26%. Short-term trend indicators are bullishly aligned (SMA20 -64.29%, SMA50 -78.97%, SMA200 -99.39%). The stock’s 14-day RSI is 23.32 (weak momentum), while the ATR of 0.75 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -99.87% below its high and over 8.92% above its low. Average 10-day trading volume of 260.97 thousand shares is below the 3-month average of 4.85 million, indicating normal recent market interest.

Profusa, Inc. Common Stock (NASDAQ:PFSA) closed at $0.51 USD, losing -$0.06 (-11.07%) from the previous close of $0.58. The stock is currently mid-range between its 52-week high and low $0.41 and $412.50. With a market capitalization of about $285.69 thousand, Profusa, Inc. Common Stock is classified as a micro-cap and shows lower-than-market volatility (beta ~0.26). Key stats such as the average daily volume over the past year has been around 4.76 million shares, volume is running light vs its 52-week average. Headquartered in EmeryVille, CA, Profusa, Inc. Common Stock operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Ben Chung-Bin Hwang, the company employs approximately 2 people and listed since July 14, 2025. A digital-health company developing tissue-integrating biosensors (e.g.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Profusa, Inc. Common Stock trades at a P/E ratio of -0.02, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -0.02 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.02, also below market averages.

Profusa, Inc. Common Stock has 36.09 million shares outstanding. The public float is 23.09 million shares, elevated short interest at 6.14% of float. This equals 1.63 million shares. The short ratio is 0.27 days. Institutional investors hold 0.61% of the float. Insiders own 37.1%.

Our AI price prediction model suggests that Profusa, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.45%, with price expected at $0.48 by May 11, 2026, within a range of $0.14 to $0.81 3-Month Outlook: Projected fall of -84.41%, reaching $0.08 by July 24, 2026, with a range of $0.00 to $1.63. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by April 27, 2027, within a range of $0.00 to $1.64.

Profusa, Inc. Common Stock (NASDAQ:PFSA) shares are flat -9.26% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Profusa, Inc. Common Stock trading at a premium to the broader market with a P/E of -0.02. Our AI forecast model points to short-term weakness (-6.45% over two weeks), a medium-term fall (-84.41% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.